PrGeneric Semaglutide 0.25
Semaglutide 0.25/0.5mg
Prescribed by licensed professionals and delivered free to your door through Stealth Health.
Generic Semaglutide 0.25 is an injectable medication used as part of a comprehensive weight management program. It helps regulate appetite and food intake.
- Supports healthy weight management
- Helps reduce appetite
- Promotes feelings of fullness
- Administered once weekly
- Part of a guided program
Indication & Clinical Use
Generic Semaglutide 0.25 is indicated for chronic weight management in adults. This includes individuals with an initial Body Mass Index (BMI) of 30 kg/m² or greater (obesity), or 27 kg/m² or greater (overweight) in the presence of at least one weight-related comorbidity such as hypertension, type 2 diabetes mellitus, or dyslipidemia.
Dosing & Administration
Generic Semaglutide 0.25 is administered as a subcutaneous injection once weekly. Dosing typically starts at a low dose and is gradually increased over several weeks to reach a target maintenance dose. Your healthcare provider will determine the appropriate dosing schedule for you.
What It Is
Generic Semaglutide 0.25 is a prescription medication. It is used in adults with obesity or overweight with at least one weight-related comorbidity, as an adjunct to a reduced-calorie diet and increased physical activity.
This medication is part of a structured program designed to support your weight management journey.
How It Works
Generic Semaglutide is a GLP-1 receptor agonist. It mimics a natural hormone in your body that helps regulate blood sugar and appetite.
It works by slowing gastric emptying, increasing feelings of fullness, and reducing overall food intake. This can lead to a reduction in body weight.
Benefits
Using generic Semaglutide 0.25 as prescribed can help support significant weight loss when combined with lifestyle changes. Many individuals experience reduced hunger and cravings.
This can make it easier to adhere to a reduced-calorie diet and achieve weight management goals.
Important Safety Information
Serious Warnings & Precautions
Generic Semaglutide 0.25 carries a boxed warning regarding the risk of thyroid C-cell tumors, including MTC. It is unknown if this medication causes thyroid C-cell tumors, including MTC, in humans. Other serious warnings include pancreatitis, gallbladder problems (cholelithiasis, cholecystitis), acute kidney injury, increased heart rate, and suicidal behavior and ideation. Inform your healthcare provider immediately if you experience any severe or unusual symptoms.
Contraindications
Generic Semaglutide 0.25 should not be used if you have a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). It is also contraindicated in patients with a prior serious hypersensitivity reaction to semaglutide or any components of the product. Do not use if you are pregnant or breastfeeding.
Common Side Effects
Common side effects may include nausea, vomiting, diarrhea, constipation, and abdominal pain. These side effects are often mild to moderate and tend to decrease over time as your body adjusts to the medication. Other common side effects can include headache, fatigue, and dyspepsia.
Drug Interactions
Generic Semaglutide 0.25 can slow gastric emptying, which may affect the absorption of orally administered medications. Caution should be exercised when co-administering oral medications, particularly those with a narrow therapeutic index. Inform your healthcare provider about all medications, supplements, and herbal products you are currently taking.
Important Safety Information
Always follow your healthcare provider's instructions for administering Generic Semaglutide 0.25. Do not share your injection pen with others, even if the needle is changed. Store the medication as directed. Seek immediate medical attention for symptoms of a severe allergic reaction, pancreatitis, or gallbladder issues. Regular follow-up with your healthcare provider is important to monitor your progress and manage any potential side effects.
Reporting Suspected Side Effects
Canada: Report suspected adverse reactions to Health Canada — Canada Vigilance Program at 1-866-234-2345. More information here.
Ready to get started with Generic Semaglutide 0.25?
Complete a quick online assessment and a licensed prescriber will review your profile.
Start Your Free Assessment